NanoViricides (NYSEAMERICAN:NNVC) Shares Up 72.6%
NanoViricides Inc (NYSEAMERICAN:NNVC)’s share price shot up 72.6% during mid-day trading on Friday . The stock traded as high as $6.73 and last traded at $9.44, 1,116,351 shares traded hands during mid-day trading. A decline of 27% from the average session volume of 1,537,851 shares. The stock had previously closed at $5.47.
NanoViricides (NYSEAMERICAN:NNVC) last issued its earnings results on Friday, November 15th. The company reported ($0.41) earnings per share (EPS) for the quarter.
About NanoViricides (NYSEAMERICAN:NNVC)
NanoViricides, Inc, a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as injectable and oral anti-influenza nanoviricide drug for H7N9, Bird Flu H5N1, other Highly Pathogenic Influenzas, Epidemic Influenzas, and Seasonal Influenzas; DengueCide, an anti-dengue nanoviricide which is in pre-clinical development; and HIVCide, an anti-human immunodeficiency virus drug candidate.
Featured Article: What are popular green investing opportunities?
Receive News & Ratings for NanoViricides Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoViricides and related companies with MarketBeat.com's FREE daily email newsletter.